⏳ Fetching live dividend data...
Home › Calculator › ECTE Dividend Calculator 2026
Echo Therapeutics, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in ECTE → $3.518788720700656e+51M in 10 years · $293,232,364,755,748,300,000,000,000,000,000,000,000,000,000,000,000,000,000.00/month
Echo Therapeutics, Inc. specializes in creating transdermal skin permeation and diagnostic medical devices. Their offerings primarily target the wearable health consumer market and individuals with diabetes requiring outpatient care. The company is currently advancing a cutting-edge, needle-free, wireless Continuous Glucose Monitoring (CGM) system, specifically tailored for hospital settings across the European Union. Echo Therapeutics maintains several strategic alliances. They hold a licensing partnership with Ferndale Pharma Group, Inc., encompassing the development, manufacturing, distribution, and commercialization of devices used for skin preparation. These devices are applied before topical anesthetics or analgesics are administered, particularly preceding a variety of needle-based medical procedures. The geographical scope of this collaboration includes North America, the United Kingdom, South America, Australia, New Zealand, Switzerland, and other regions within the European Union. Furthermore, the company has secured a licensing arrangement with Handok Pharmaceuticals Co., Ltd. This partnership covers the development, utilization, marketing, importation, and sale of its CGM technology to both healthcare institutions and private individuals in South Korea. A separate license, development, and commercialization agreement is also in effect with Medical Technologies Innovation Asia, Ltd., focusing on the research, development, production, and deployment of CGM systems throughout the People's Republic of China, Hong Kong, Macau, and Taiwan. Established in 1989, Echo Therapeutics, Inc. maintains its principal office in Iselin, New Jersey.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ECTE position with:
Real after-tax yield depends on where you live and how you hold ECTE.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 800000.00% | 799997.20% | $80,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 912500.00% | 912497.20% | $91,250,000 / yr |
| 🇨🇦 TFSA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 750000.00% | 749997.20% | $75,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 736250.00% | 736247.20% | $73,625,000 / yr |
| 🇫🇷 FR Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ECTE pays quarterly — 4 times per year. Next ex-div: TBD.
How ECTE compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ECTE sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2017-03-21 | 25,000 | — | — | ||
| A-Award | 2016-03-21 | 150,000 | $2.00 | $300.0K | ||
| A-Award | 2016-03-01 | 150,000 | $1.12 | $168.0K | ||
| J-Other | 2014-12-18 | 1,052,410 | — | — | ||
| J-Other | 2014-12-18 | 1,052,410 | — | — | ||
| J-Other | 2014-12-18 | 447,590 | — | — | ||
| Buy | 2014-12-18 | 420,168 | — | — | ||
| J-Other | 2014-12-18 | 447,590 | — | — | ||
| Buy | 2014-12-18 | 1 | $3.00 | $3.00 | ||
| A-Award | 2015-01-07 | 150,000 | $1.62 | $243.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ECTE dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →